Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Carboplatin in TNBC with Residual Disease (POST-Neo Adjuvant Study)
NCT01752686Phase 3Unknown
- Sponsor
- Severance Hospital
- Start
- Mar 2013
- Primary completion
- Mar 2017
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 3 trial of carboplatin in triple negative breast cancer (TNBC), sponsored by Severance Hospital. Status: unknown.
02
Drugs
carboplatin
03
Conditions
triple negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01752686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01752686.